News
Atracurium Intravenous Infusion for Ventilated Adult Patients
Who can administer
Administration RESTRICTED - see Appendix 1
Important information
- To be used only in a critical care setting for ventilated patients
- Consideration should be given to dosing obese patients based on Ideal body weight, or an adjusted body weight (ref 1)
- As this is a neuromuscular blocker particular care and attention should be focused on the safe storage and distribution of this drug so as to minimise the risk of right patient wrong drug
- This monograph relates ONLY to the use in critical care for paralysis relating to ARDS
- For complete information and guidance refer to the manufacturers SPC on www.medicines.ie
- For Y-site compatibility see below
Available preparations
Atracurium (Tracrium) 25mg in 2.5ml ampoules
Atracurium (Tracrium) 250mg in 25ml ampoules
Reconstitution
Already in solution
Draw up using a 5 micron filter needle
Infusion fluids
Sodium chloride 0.9% or Glucose 5% (if required)
Methods of intravenous administration
Bolus intravenous injection
- Administer by rapid intravenous injection
- Administer more slowly over 1 to 2 minutes for patients with significant cardiovascular disease or hypovolaemia (ref 2)
Continuous Intravenous Infusion
- Use undiluted - 500mg in 50ml via a syringe pump
Dose in adults
Intensive care unit paralysis (eg, use for up to 48 hours in patients with early ARDS with PaO2/FiO2 <150, to facilitate mechanical ventilation, or for shivering from therapeutic hypothermia) (unlicensed) (ref 1)
- Initial bolus of 0.4 to 0.5mg/kg, followed by continuous IV infusion of 4 to 20 mcg/kg/minute (0.24 to 1.2 mg/kg/hour)
- Note: maximum licensed dose is 0.6mg/kg/hour
- See table below for quick reference
40kg | 50kg | 60kg | 70kg | 80kg | 90kg | 100kg | 110kg | 120kg | |
---|---|---|---|---|---|---|---|---|---|
Loading dose 0.45mg/kg | 18mg | 22.5mg | 27mg | 31.5mg | 36mg | 40.5mg | 45mg | 49.5mg | 54mg |
Maintenance dose | Using undiluted injection solution 500mg in 50ml- rate in ml/hour | ||||||||
4mcg/kg/min (0.24mg/kg/hour) | 0.96 | 1.2 | 1.4 | 1.7 | 1.9 | 2.2 | 2.4 | 2.6 | 2.9 |
6.6mcg/kg/min (0.4mg/kg/hour) | 1.6 | 2 | 2.4 | 2.8 | 3.2 | 3.6 | 4 | 4.4 | 4.8 |
10mcg/kg/min (0.6mg/kg/hour) | 2.4 | 3 | 3.6 | 4.2 | 4.8 | 5.4 | 6 | 6.6 | 7.2 |
20mcg/kg/min (1.2mg/kg/hour) (unlicensed dose once over 0.6mg/kg/hour) | 4.8 | 6 | 7.2 | 8.4 | 9.6 | 10.8 | 12 | 13.2 | 14.4 |
Storage
Store in a refrigerator at 2-80C
References
1. Uptodate- accessed online 11 Nov 2021
2. Medusa NHS Injectable medicines acccessed online 11 Nov 2021
Therapeutic classification
Neuromuscular blocking agent
BNF